Eco Animal Health Group plc is engaged in the development, registration and marketing of pharmaceutical products for global animal health markets. The Company's principal activity is the manufacture and supply of animal health products across the globe. These activities are conducted on a global scale, through a network, including both regional offices (notably in Shanghai and Princeton) and overseas subsidiaries. The Company's products include Aivlosin and Ecomectin. Aivlosin is an antibiotic that treats a range of specific enteric (gut) and respiratory diseases in pigs and poultry. Ecomectin is an endectocide that controls worms, ticks, lice and mange in grazing stock and pigs. It operates in the United Kingdom and Europe, the Far East, Latin America, North America, and the Middle East and Africa. Its subsidiaries include Eco Animal Health Limited and ECO Animal Health do Brasil Comercio de Produtos Veterinarios Ltda.

Pharmaceutical

ECO Animal Health Group PLC

David Charles Hallas

David Hallas

The Leadership Team at ECO Animal Health Group PLC is responsible for setting the strategic direction and vision of the company, ensuring regulatory compliance, overseeing product lifecycle management, and maintaining financial health. This team includes the Chief Executive Officer, who drives overall company strategy; the Global Head of Quality & Regulatory Affairs, who ensures product standards and lifecycle management; and the Chief Financial Officer, who manages financial planning and performance. Their combined expertise is critical to steering the company towards sustainable growth and success in the global animal health market.

Leadership Team

About

Team members

Other teams at ECO Animal Health Group PLC

Sales And Marketing

Finance and Control